What should marketing and medical affairs invest in for Q4? - European Medical Journal

What should marketing and medical affairs invest in for Q4?

EMJ GOLD
Series 8: Episode 7

As 2024 draws to a close, what should pharma teams be focusing their budgets on for the final quarter of the year?

Join Jade and Isabel as they explore the critical trends that have shaped the industry in 2024. As teams finalise their budgets and plan for the final quarter and year ahead, this conversation brings insights into how strategies like personalised engagement, thought leadership and interactive, on-demand content are making an impact. With real-life examples, learn about the tools you can invest in to end the year on a high.

Read our article exploring the topic further here.

Rate this content's potential impact on patient outcomes

Average rating / 5. Vote count:

No votes so far! Be the first to rate this content.

Thank you!

Please share some more information on the rating you have given